BNB Plus Corp. (OTCPK: BNBX)
Health Care · Life Sciences Tools & Services · US
$0.14
+3.74% today · -96.7% 1Y
BNB Plus Corp. (OTCPK: BNBX) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $867.92K and employs 26 people.
Over the last twelve months the share price has lost 96.7%, trading between 0.07 and 6.17.
Tweenvest scores BNB Plus Corp. across four factors: quality 36/100, value 46/100, growth 0/100. Its strongest factor is value.
BNBX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $867.92K
- Revenue (TTM)
- $2.39M
- P/E
- —
- EPS
- -6.34
- Dividend yield
- —
- Beta (5Y)
- 0.61
- 52-week high
- $6.17
- 52-week low
- $0.07
- Avg volume (3M)
- —
- Shares outstanding
- 6.20M
- Employees
- 26
- Next earnings
- —
About BNB Plus Corp.
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
- ISIN
- US03815U6073
- Founded
- 1983
- Listed since
- Oct 8, 2025
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Level Bio AB (publ)NGM: LEVBIO | $1.66M | Skr0.24 | +7.96% |
| Vanta Bioscience LimitedBSE: 540729 | $1.59M | Rs21.49 | +9.87% |
| Magle Chemoswed Holding AB (publ)OM: MAGLE | $1.46M | Skr0.40 | -17.36% |
| CDT Equity Inc.NasdaqCM: CDT | $1.11M | $0.80 | -19.19% |
| Attana AB (publ)NGM: ATANA | $514.29K | Skr0.00 | -33.33% |
| Inhalation Sciences Sweden AB (publ)XSAT: ISAB | $415.43K | Skr0.09 | +5.68% |
| MetaStat, Inc.OTCPK: MTST | $319.73K | $— | — |
| EVIO, Inc.OTCPK: EVIO | $20.73K | $0.00 | — |
Figures last refreshed Oct 4, 2026.